PATENT CLAIM ANALYSIS

Application Number: 15745615
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "567000"]

Abstract:
The present invention relates to stabilized liquid formulations of Levothyroxine or a pharmaceutically acceptable salt thereof, intended for parenteral administration. Further this invention also describes process of preparing such compositions.

Claim (Index 6):
A stable, liquid parenteral pharmaceutical formulation of  claims 4  and  5 , wherein the cyclodextrin is selected from \u03b1, \u03b2 and \u03b3-cyclodextrin and cyclodextrins modified with alkyl-, hydroxyalkyl-, dialkyl-, and sulfoalkyl-ether modified cyclodextrins such as methyl or hydroxypropyl \u03b2-cyclodextrins (HP\u03b2CD), sulfoalkylether-substituted beta-cyclodextrin, sulfobutylether-\u03b2-cyclodextrin (SBECD).

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.1
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15366864', '15700258', '15750068', '12160292', '14946947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7736585604940373
- 35 USC 102 Novelty (BERT): 0.4973354651256083
- Combined Prediction Score: 0.7460262509571943
- Mean Citation Score: 219.44458
- Max Citation Score: 251.2581
- Similarity Product: 196.2619638586521

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test